150Mg Erlotinib Tablets

About 150Mg Erlotinib Tablets

Erlonat (Erlotinib) is a Kinase inhibitor which is primarily used to treat cell lung cancer, or pancreatic cancer when combined with a certain other medicine. It works by inhibiting growth to adjacent tissues in the body so that the cancerous cells slow down, allowing the patient a better environment to recover and fight the cancer naturally.

Erlonat contains erlotinib and belongs to a class of medications called kinase inhibitors.

Used for:

Erlonat is used for the treatment of non-small cell lung cancer. Erlonat is used in combination with gemcitabine for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body.

Manufactured By : NATCO

Specification:

•     Product Name : Erlonat
•     Contains : Erlotinib hydrochloride
•     Form : Tablet
•     Strength : 100 mg & 150 mg
•     Packing : Pack Of 30 Tabs

 

Key Features of Erlotinib Tablets

These tablets stand out for their high purity (99%), consistent pharmaceutical grade quality, and oval, easy-to-swallow form. Each blister pack ensures the medication stays protected from moisture and light, ensuring maximum shelf life and efficacy. Suitable for hospital, clinic, or personal use, Erlotinib tablets support treatment protocols for specific cancer types.


Usage and Administration Guidelines

Erlotinib tablets are taken orally, usually once a day, exactly as directed by a physician. Dosage instructions must be followed strictly to maximize therapeutic benefit. Regular consultation with healthcare professionals is recommended to monitor progress and manage side effects.


Clinical Benefits and Applications

Erlotinib is widely prescribed for treating non-small cell lung cancer and pancreatic cancer due to its proven efficacy. When incorporated into approved treatment regimens, patients may experience slowed disease progression and improved management of cancer symptoms as determined by the attending oncologist.